TrialAntimicrobial agents and chemotherapy2023

Safety, tolerability, and pharmacokinetics of ibrexafungerp in healthy Chinese subjects: a randomized, double-blind, placebo-controlled phase 1 trial.

Xiaoyan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.